Literature DB >> 21466620

Pathophysiology, prevention and management of chronic kidney disease in the hypertensive patient with diabetes mellitus.

Anna Solini1, Ele Ferrannini.   

Abstract

The authors concisely review the main clinical issues arising in the management of the hypertensive patient with type 2 diabetes, in whom chronic kidney disease is prevalent and heralds increased cardiovascular morbidity and mortality. Special attention is paid to the clinical meaning, relevance and limits of albumin excretion and glomerular filtration rate, the two widely used markers of reduced kidney function during the course of chronic diseases like diabetes and hypertension. The main therapeutic strategies involving blood pressure and glycemic control, treatment of dyslipidemia and improvement of lifestyle are discussed from the viewpoint of a general practitioner dealing with the clinical complexity of these patients.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21466620      PMCID: PMC8673134          DOI: 10.1111/j.1751-7176.2011.00446.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  47 in total

1.  Establishing pragmatic estimated GFR thresholds to guide metformin prescribing.

Authors:  J S Shaw; R L Wilmot; E S Kilpatrick
Journal:  Diabet Med       Date:  2007-08-02       Impact factor: 4.359

2.  Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

Authors:  Ravi Retnakaran; Carole A Cull; Kerensa I Thorne; Amanda I Adler; Rury R Holman
Journal:  Diabetes       Date:  2006-06       Impact factor: 9.461

Review 3.  Chronic kidney disease and mortality risk: a systematic review.

Authors:  Marcello Tonelli; Natasha Wiebe; Bruce Culleton; Andrew House; Chris Rabbat; Mei Fok; Finlay McAlister; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

4.  Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention.

Authors:  Paolo Verdecchia; Gianpaolo Reboldi; Fabio Angeli; Roberto Gattobigio; Maurizio Bentivoglio; Lutgarde Thijs; Jan A Staessen; Carlo Porcellati
Journal:  Hypertension       Date:  2005-07-11       Impact factor: 10.190

Review 5.  Nephropathy in type 2 diabetes.

Authors:  E Ritz
Journal:  J Intern Med       Date:  1999-02       Impact factor: 8.989

6.  Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.

Authors:  Bruce A Perkins; Robert G Nelson; Betsy E P Ostrander; Kristina L Blouch; Andrzej S Krolewski; Bryan D Myers; James H Warram
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

7.  Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects.

Authors:  Fabio Angeli; Paolo Verdecchia; Gian Paolo Reboldi; Roberto Gattobigio; Maurizio Bentivoglio; Jan A Staessen; Carlo Porcellati
Journal:  Am J Hypertens       Date:  2004-09       Impact factor: 2.689

8.  Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.

Authors:  Dick de Zeeuw; Giuseppe Remuzzi; Hans-Henrik Parving; William F Keane; Zhongxin Zhang; Shahnaz Shahinfar; Steve Snapinn; Mark E Cooper; William E Mitch; Barry M Brenner
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

9.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

10.  Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.

Authors:  Sophia Zoungas; Bastiaan E de Galan; Toshiharu Ninomiya; Diederick Grobbee; Pavel Hamet; Simon Heller; Stephen MacMahon; Michel Marre; Bruce Neal; Anushka Patel; Mark Woodward; John Chalmers; Alan Cass; Paul Glasziou; Stephen Harrap; Liu Lisheng; Guiseppe Mancia; Avinesh Pillai; Neil Poulter; Vlado Perkovic; Florence Travert
Journal:  Diabetes Care       Date:  2009-08-03       Impact factor: 19.112

View more
  6 in total

1.  Long-term treatment of diabetic rats with vanadyl sulfate or insulin attenuate acute focal cerebral ischemia/reperfusion injury via their antiglycemic effect.

Authors:  Hossein Ahmadi-Eslamloo; Gholam Abbas Dehghani; Seyed Mostafa Shid Moosavi
Journal:  Metab Brain Dis       Date:  2017-11-19       Impact factor: 3.584

Review 2.  Effects of dual inhibition of renin-angiotensin-aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits.

Authors:  Giuliano Tocci; Barbara Citoni; Vivianne Presta; Giovanna Leoncini; Francesca Viazzi; Barbara Bonino; Massimo Volpe; Roberto Pontremoli
Journal:  Intern Emerg Med       Date:  2019-12-21       Impact factor: 3.397

3.  Lifestyle change important for patients with hypertension and cardiovascular diseases.

Authors:  Murat Karaman; Sevket Balta; Mustafa Cakar; Seyid A Ay; Mustafa Dinc
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-01       Impact factor: 3.738

4.  Rice bran modulates renal disease risk factors in animals submitted to high sugar-fat diet.

Authors:  Juliana Silva Siqueira; Fabiane Valentini Francisqueti-Ferron; Jéssica Leite Garcia; Carol Cristina Vágula de Almeida Silva; Mariane Róvero Costa; Erika Tiemi Nakandakare-Maia; Fernando Moreto; Ana Lúcia A Ferreira; Igor Otávio Minatel; Artur Junio Togneri Ferron; Camila Renata Corrêa
Journal:  J Bras Nefrol       Date:  2021 Apr-Jun

5.  Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus.

Authors:  Vishal J Patel; Amit A Joharapurkar; Samadhan G Kshirsagar; Brijesh K Sutariya; Maulik S Patel; Hiren M Patel; Dheerendra K Pandey; Rajesh H Bahekar; Mukul R Jain
Journal:  World J Diabetes       Date:  2018-06-15

6.  Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample.

Authors:  Christopher S Lee; Christopher V Chien; Julie T Bidwell; Jill M Gelow; Quin E Denfeld; Ruth Masterson Creber; Harleah G Buck; James O Mudd
Journal:  BMC Cardiovasc Disord       Date:  2014-06-05       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.